MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received $48.1 million in net cash […]
Fully defined, synthetic ECM designed to improve reproducibility and reduce lot-to-lot variability Supports standardization of scalable 3D stem cell and organoid workflows Synthetic alternative to traditional matrices, enabling consistent performance while aligning with regulatory and translational initiatives MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the […]
New York, New York — Peptide Hubs, a premier American-based supplier of high-purity research compounds, is thrilled to announce the official launch of six groundbreaking additions to its product catalog. This strategic expansion features some of the most sought-after compounds in modern biochemistry: Copper Peptide GHK-Cu, GHRP-6 Peptide, Adipotide Peptide, Selank, IGF-1 LR3, and Chonluten. […]
Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at close, excluding potential future earnouts, to fuel inorganic growth strategy Continuing Operations on track to achieve positive adjusted EBITDA in 2026 BOSTON, Mass. — Standard BioTools Inc. (NASDAQ: LAB) […]
Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumina’s NGS ecosystem, DRAGEN software, and Illumina Connected Multiomics to rapidly transform insights into discoveries SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in […]
PALO ALTO, Calif. — Leading GMP cell therapy CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it has successfully generated human induced pluripotent stem (iPS) cells from NKT cells and has begun offering them for research use. NKT cells are immune cells known to possess characteristics […]
COLUMBIA, Md. — Shimadzu Scientific Instruments, Inc., a leading provider of analytical instrumentation, announces it has entered a collaboration with Georgia Southern University through its Shimadzu Partnership for Academics, Research and Quality of Life (SPARQ) program. Representatives from Georgia Southern University and Shimadzu announced the partnership after signing the official agreement this week. This strategic […]
Collaboration enhances life science lab connectivity by integrating automated imaging and detection systems into research workflows SAN JOSE, Calif. – Molecular Devices, LLC., a leading provider of high‑performance life science solutions and an operating company of Danaher Corporation (NYSE:DHR), today announced a new collaboration with Automata, the London‑based lab automation company developing fully integrated, AI‑ready platforms […]
Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to deliver approximately $3 million in cost savings in 2027 and $4 million in annual cost savings beginning in 2028 while improving throughput and execution HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today […]
Gene therapy developers and manufacturers adopting NanoMosaic’s platform gain access to enhanced FDA engagement and expedited IND/BLA review. The FDA AMT designation verifies NanoMosaic platform’s ability to enhance efficiency, product quality, and scalability across AAV gene therapy manufacturing. WALTHAM, Mass. — NanoMosaic, a leader in advanced analytical technologies for cell and gene therapy development and manufacturing, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
